Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,502 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety of beta-blocker discontinuation after acute coronary syndromes with preserved or mildly reduced left ventricular ejection fraction: a target trial emulation from a real-world cohort.
Johner N, Branca M, Carballo D, Baggio S, Nanchen D, Tessitore E, Räber L, Lüscher TF, Matter CM, Windecker S, Rodondi N, Mach F, Gencer B. Johner N, et al. Among authors: windecker s. Eur J Prev Cardiol. 2024 Oct 26:zwae346. doi: 10.1093/eurjpc/zwae346. Online ahead of print. Eur J Prev Cardiol. 2024. PMID: 39454630
Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.
Windecker S, Remondino A, Eberli FR, Jüni P, Räber L, Wenaweser P, Togni M, Billinger M, Tüller D, Seiler C, Roffi M, Corti R, Sütsch G, Maier W, Lüscher T, Hess OM, Egger M, Meier B. Windecker S, et al. N Engl J Med. 2005 Aug 18;353(7):653-62. doi: 10.1056/NEJMoa051175. Epub 2005 Aug 16. N Engl J Med. 2005. PMID: 16105989 Free article. Clinical Trial.
Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial.
Togni M, Eber S, Widmer J, Billinger M, Wenaweser P, Cook S, Vogel R, Seiler C, Eberli FR, Maier W, Corti R, Roffi M, Lüscher TF, Garachemani A, Hess OM, Wandel S, Meier B, Jüni P, Windecker S. Togni M, et al. Among authors: windecker s. J Am Coll Cardiol. 2007 Sep 18;50(12):1123-31. doi: 10.1016/j.jacc.2007.06.015. Epub 2007 Sep 4. J Am Coll Cardiol. 2007. PMID: 17868802 Free article. Clinical Trial.
Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patients.
Billinger M, Beutler J, Taghetchian KR, Remondino A, Wenaweser P, Cook S, Togni M, Seiler C, Stettler C, Eberli FR, Lüscher TF, Wandel S, Jüni P, Meier B, Windecker S. Billinger M, et al. Among authors: windecker s. Eur Heart J. 2008 Mar;29(6):718-25. doi: 10.1093/eurheartj/ehn021. Epub 2008 Feb 12. Eur Heart J. 2008. PMID: 18272504 Free article. Clinical Trial.
Biolimus-eluting biodegradable polymer versus sirolimus-eluting permanent polymer stent performance in long lesions: results from the LEADERS multicentre trial substudy.
Wykrzykowska JJ, Räber L, de Vries T, Bressers M, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice MC, di Mario C, Regar E, Jüni P, Windecker S, Serruys PW. Wykrzykowska JJ, et al. Among authors: windecker s. EuroIntervention. 2009 Aug;5(3):310-7. doi: 10.4244/v5i3a49. EuroIntervention. 2009. PMID: 19736154 Free article. Clinical Trial.
The DESIRE-Late registry: what is left to be desired?
Windecker S, Räber L. Windecker S, et al. JACC Cardiovasc Interv. 2010 Jan;3(1):19-21. doi: 10.1016/j.jcin.2009.11.008. JACC Cardiovasc Interv. 2010. PMID: 20129563 Free article. No abstract available.
Current status of drug-eluting stents.
Räber L, Windecker S. Räber L, et al. Among authors: windecker s. Cardiovasc Ther. 2011 Jun;29(3):176-89. doi: 10.1111/j.1755-5922.2010.00144.x. Epub 2010 Mar 29. Cardiovasc Ther. 2011. PMID: 20370793 Free article. Review.
1,502 results